Fourth study published over two-year span that analyzes key leukemia protein
Northwestern Medicine scientists have discovered two successful therapies that slowed the progression of pediatric leukemia in mice, according to three studies published over the last two years in the journal Cell, and the final paper published Dec. 20 in Genes & Development.
When a key protein responsible for leukemia, MLL, is stabilized, it slows the progression of the leukemia, the most recent study found. The next step will be to combine the treatments from the past two years of research into a pediatric leukemia “super drug” to test on humans in a clinical trial.
The survival rate is only 30 percent for children diagnosed with MLL-translocation leukemia, a cancer that affects the blood and bone marrow. Patients with leukemia have a very low percentage of red blood cells, making them anemic, and have approximately 80 times more white blood cells than people without cancer.
30%Current survival rate for pediatric leukemia patients.
“These white blood cells infiltrate many of the tissues and organs of the affected individuals and is a major cause of death in leukemia patients,” said senior author Ali Shilatifard, the Robert Francis Furchgott Professor of Biochemistry and Molecular Genetics and Pediatrics, the chairman of biochemistry and molecular genetics and the director of Northwestern’s Simpson Querrey Center for Epigenetics. “This is a monster cancer that we’ve been dealing with for many years in children.”
There are several types of leukemia. This research focused on the two most common found in infants through teenagers: acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL).
For the past 25 years, Shilatifard’s laboratory has been studying the molecular function of MLL within its complex known as COMPASS (Complex Proteins Associated with Set1). Most recently, it was demonstrated that COMPASS components are one of the most frequently identified mutations in cancer.The next step of this work will be to bring the drug to a clinical trial setting, which Shilatifard said he hopes will happen in the next three to five years.
“I’ve been working on this translocation for more than two decades, and we’re finally at the point where in five to 10 years, we can get a drug in kids that can be effective,” Shilatifard said. “If we can bring that survival rate up to 85 percent, that’s a major accomplishment.”
Earlier work from Shilatifard’s laboratory published in Cell in 2018 identified compounds that could slow cancer growth by interrupting a gene transcription process known as “Super Elongation Complex” (SEC). It was the first compound in its class to do this.
This MLL stabilization process discovered in the most recent paper could potentially work in cancers with solid tumors, such as breast or prostate cancer, said first author Zibo Zhao, a postdoctoral research fellow in Shilatifard’s lab.
“This opens up a new therapeutic approach not only for leukemia, which is so important for the many children who are diagnosed with this terrible cancer, but also for other types of cancers that plague the population,” Zhao said.
“The publication of these four papers and the possibility of a future human clinical trial could not have happened if it weren’t for the cross-disciplinary collaboration at Northwestern,” Shilatifard said.
Learn more: Pediatric leukemia ‘super drug’ could be developed in the coming years
The Latest on: Pediatric leukemia
[google_news title=”” keyword=”pediatric leukemia” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Pediatric leukemia
- “Our Rayne of Sunshine” blood drive hosted in honor of local five-year-old battling leukemiaon April 28, 2024 at 6:53 am
Rayne was diagnosed with leukemia in April of 2022 at the age of three ... All proceeds will benefit Families of Children with Cancer, a local nonprofit founded by parents and healthcare professionals ...
- Montefiore Children’s Hospital holds special prom for teenage patientson April 26, 2024 at 7:35 pm
Teenage patients battling long-term health challenges at the Children’s Hospital at Montefiore were treated to an unforgettable prom experience, giving them a chance to embrace a sense of normalcy ...
- Chase O’Donnell’s courageous fight against leukemia an inspiration to his Hopkinton lacrosse teammates, coacheson April 24, 2024 at 3:22 pm
After a leukemia diagnosis last year led to a missed year of high school, O’Donnell is repeating his sophomore year, but starring alongside a strong class of 2025 on the field for the No. 18 Hillers ...
- Ramona kindergartener fighting leukemia gets a dream Make-A-Wish dayon April 23, 2024 at 7:00 pm
When she was recently selected as a “Wish Kid” by Make-A-Wish San Diego, her biggest wish was a play structure, where all those she loves, including the pigs, can spend time together outdoors. On ...
- Opponents Come Together to Raise $10,000 for Pediatric Cancer Research, Honor Olivia Allenon April 23, 2024 at 4:14 pm
Saratoga girl's lacrosse, along with their opponent, Jamesville-Dewitt, teamed up for the "Lacrosse Out Cancer" challenge in honor of Olivia Allen.
- Ancient DNA Reveals Origin of Racial/Ethnic Disparity in a Childhood Canceron April 23, 2024 at 12:15 pm
Researchers discovered a genetic variant linked with higher rates of acute lymphoblastic leukemia (ALL) in Latino children.
- Chandler mom seeks funds, donor match for toddler with leukemiaon April 20, 2024 at 9:15 am
Destiny Martinez isn’t at home in Chandler much these days. She spends most of her time at an area hospital, where her son, Ollie, spends most of his days as a leukemia patient in need ...
- Teenage leukaemia patient honoured for 'kindness towards others'on April 20, 2024 at 1:15 am
Mia Harris Jones from Cardiff has been awarded Youth Ambassador status for helping other children diagnosed with cancer | ITV News Wales ...
- Pittsburgh-area high school students raise $800K for Leukemia and Lymphoma Societyon April 18, 2024 at 5:05 pm
PINE TOWNSHIP, Pa. (KDKA) -- The Leukemia and Lymphoma Society recently recognized several fundraising teams for collecting a total of $802,000 for the nonprofit organization. And those teams are ...
- Potential new treatment strategy for aggressive leukemiaon April 18, 2024 at 7:11 am
Scientists have found a potential treatment strategy for an aggressive type of leukemia by targeting enzymes used by cells to sense and adapt to oxygen levels.
via Bing News